Pharmacovigilance for COVID-19 booster vaccine

Regular COVID-19 vaccine boosters are likely to become the standard with associated vaccine booster mandates. It is imperative to ensure safety through proper pharmacovigilance. Who has this important responsibility?

All patients who have had a booster vaccine should be followed up on a weekly basis for 8 weeks with a telephone call to document any sympt…